Alt
/content/dam/asset-migration/headshots/uk-doctor-headshots/UK_Doctor-Profile_280x280px_Dr-Stephen-Falk.jpg

Dr Stephen Falk

Dr Stephen Falk
Stephen
Falk
MB, ChB, MRCP, FRCR, MD, Consultant Clinical Oncologist

Languages spoken

English

Expert in

Chemotherapy and radiotherapy

Overview

Centres

Bristol
Bristol

300 Park Avenue, Aztec West, Bristol BS32 4SY

51.541807689358095, -2.5709663094294277
/uk/our-centres/bristol
+44 (0)1454 456500
mediahawkNumber4110 mhMobile

Specialises in

Genitourinary cancer
Condition
Condition/Cancer
Condition/Cancer/Genitourinary cancer
Lung cancer
Condition
Condition/Cancer
Condition/Cancer/Lung cancer

Treatments

Chemotherapy
Service
Service/Cancer
Service/Cancer/Medical oncology
Service/Cancer/Medical oncology/Chemotherapy
Radiotherapy
Service
Service/Cancer
Service/Cancer/Radiotherapy
Stereotactic ablative radiotherapy (SABR)
Service
Service/Cancer
Service/Cancer/Radiotherapy
Service/Cancer/Radiotherapy/Stereotactic ablative radiotherapy (SABR)

Special clinical interest in lung; oesophageal; stomach and colorectal cancer.

Dr Falks major clinical interests are thoracic (lung) and gastro-intestinal malignancies (oesophagusstomachpancreascolo-rectal).

He provides specialist chemotherapy and radiotherapy treatments, often in combination. A major interest in clinical research was stimulated as a MRC Clinical Scientist in Cambridge where the MRC cancer trials unit was situated at the time. He has an MD related to lung cancer and scheduling of topoisomerase poisons, with and without radiation, which is the basis of on-going interest in chemo-radiotherapy and new drugs.

All patients who are referred will be offered an appropriate clinical trial.

Careerpositions

Career positions

Current position(s)

  • Consultant Clinical Oncologist, Honorary Senior Lecturer Bristol Haematology and Oncology centre

Clinical interests

  • Treatment of Oeosophago-gastric, hepatobiliary, pancreatic and Colorectal Cancer

Dr Stephen Falk reviews